字級縮小
字級縮小
字級放大
字級放大

Investment Banking

The capital markets department assists domestic and foreign companies in handling capital market transactions such as initial public offerings in the TWSE or TPEx markets, the issuances of securities to raise funds, providing consulting services regarding corporate finance or business planning, business spin-offs, strategic alliances, mergers & acquisitions, etc.

KGI Securities will continue to cultivate industries such as tech, non-tech, retail, biotech and medical services, fully grasp market development trends, expand the market share of various capital market businesses through the integration of group resources of CDF, leverage advantages in corporate financing, leasing, and direct investment, and deepen the layout of cross-strait enterprises to provide complete and high-quality investment banking services to Chinese and Taiwanese customers worldwide.
 
Awards and achievements
1. Capital market business
   -Won “Best Contributor Award” for advising IPOs on the TPEx market,
      and was runner-up for “TPEx IPO Advising Performance Award.”
   -Runner-up of “Equity-market Liquidity-boosting as an Underwriter” by TWSE.
2. Financial advisory business
   -Ranked 1st in Taiwan in number of advisory cases undertaken since 2015 by Bloomberg.
   -Named the Best M&A Advisor of 2019 by The Asset
   -The merger of Gintech and Solartech Energy Corp by Neo Solar Power, and the acquisitions of Yungtay Engineering by
     Hitachi and LCY Chemical Corp by private equity firm KKR were respectively named the Best Domestic M&A Deal,
     Best Cross-border M&A Deal and Best LBO Deal of 2019 by The Asset.
   -There were a total of 35 IPOs on the TWSE and TPEx markets in 2019, down from 60 in 2018 as a result of the
     Sino-US trade war. However, given sufficient market funds, the Taiex Index remained above 10,000 points, attracting
     more companies to make public offerings in the open market. 
     --There were 78 fundraising projects, including 8 preferred share issuances, 71 convertible bond issuances and 31 IPOs
        made on the Taiex market, adding up to 184 underwriting projects, down slightly by 3% from 190 in 2018.
     --The underwriting market value in 2019 was NT$84.1bn, down 13% YoY from NT$96.8bn in 2018.
   -KGI Securities was the lead underwriter of 33 fundraising projects in 2019, representing an 18% market share,
    which was the highest among peers.
   -In 2019, KGI Securities facilitated the IPOs of ZillTek Technology, EirGenix, FitTech and Crystalvue on the TWSE and
    OTC markets, as well as the listing of Lotus Pharmaceutical on the main board from TPEx, which is the first case of
    a listing under Taiwan’s diverse listing scheme.
   -For fundraising, KGI Securities served as the lead underwriter of 16 rights issuances
    (including 5 preferred share issuances) and 12 convertible bond issuance projects.
    --Some of the major fundraising projects that KGI Securities processed in 2019 included those of Taishin FHC,
       Kwong Lung, EVA Airways, CSBC Corp., Solar Applied Materials Tech, Foresee Pharmaceuticals, PCL Technologies,
       Shin Kong FHC, WPG, United Orthopedic, Arcadyan, Sigurd, Tranvex, Airmate, URE, Singtex, Gemtek, TaiDoc,
       Global Tek, Chilisin, Alltop Technology, Quang Viet and Episil-Precision.
 
In summary, KGI Securities has been a leading market player in terms of its number of IPO handling and underwriting market value in 2019, enabling a number of companies to raise capital in TWSE/TPEx markets.